Rohto Pharmaceutical Co (JP:4527) has released an update.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Rohto Pharmaceutical Co. reported a significant decline in profits for the first half of fiscal year 2025, with net income dropping by 22.1% compared to the previous year, despite an 8.8% rise in net sales. The company has also revised its dividend forecast, reflecting cautious optimism for the remainder of the fiscal year.
For further insights into JP:4527 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue